Risk factors for retained placenta




Materials and Methods


We performed a secondary analysis of deidentified data collected from the Consortium on Safe Labor database, a retrospective cohort study of 228,562 deliveries from 12 US clinical centers between 2002 and 2008. Data were collected from obstetric, labor progression, and newborn electronic medical records linked to hospital discharge codes. This original study received institutional review board approval from all participating institutions, and the current analysis was deemed exempt by the MedStar Washington Hospital Center’s Institutional Review Board on Oct. 17, 2013.


For the present analysis, we included women with singleton gestations, delivery gestational age ≥ 24 weeks, and vaginal deliveries. Only the patient’s first documented pregnancy in the Consortium on Safe Labor database was used for analysis. Cases with shoulder dystocia or hospitals without adequate documentation of pertinent variables were excluded ( Figure 1 ). The total number of deliveries available for analysis was 91,291.




Figure 1


Case selection diagram

GA , gestational age.

Coviello. Risk factors for retained placenta. Am J Obstet Gynecol 2015 .


The third stage of labor was calculated from the time of neonate delivery to the time of placental delivery as recorded in the electronic medical record. Retained placenta was defined as longer than 30 minutes. Bivariate analyses were performed to assess the relationship between a retained placenta and maternal demographic or clinical characteristics with a χ 2 test, Fisher exact test, Student t test, or Wilcoxon rank sum test, if applicable. Multivariable logistic regression analyses estimated the adjusted odds ratios and 95% confidence intervals for potential risk factors for retained placenta stratified by parity.


Risk factors for retained placenta were identified from the medical record or International Classification of Disease , 9th revision (ICD-9), codes and included parity, maternal age, gestational age, admission BMI, race, history of abortion (ICD-9), history of cesarean delivery, large for gestational age (ICD-9), intrauterine growth restriction (IUGR; ICD-9), duration of first and second stages of labor, duration of rupture of membranes to delivery, labor induction agent (misoprostol, dinoprostone, artificial rupture of membranes, or oxytocin), group B streptococcal status, chorioamnionitis, use of an epidural, episiotomy, stillbirth, hospital type, and duration of exposure to oxytocin were examined and adjusted for in the analysis.


A value of P < .05 was determined significant. Forest plots were developed to compare the odds ratios between categories of gestational age groups, based on the result of multivariable logistic regression models. All statistical analyses were performed using SAS version 9.3 (SAS Institute Inc, Cary, NC).




Results


The incidence of retained placenta in the study population was 1.12% (1047 deliveries). The demographics of the study population are described in Table 1 . Women with retained placenta compared with women without retained placenta were more likely to be older (27.5 years vs 26.6 years; P < .001), multiparous, and non-Hispanic black or Asian, but there was no difference in maternal BMI ( P < .18).



Table 1

Demographic and obstetrical risk factors for retained placenta








































































































































































































































































































































































































































Variable a Retained placenta no (n = 89,765) Retained placenta yes (n = 1047, 1.12%) P value
Maternal age, y b 26.64 (5.81) 27.53 (6.43) < .001
Gravidity c 2 (1,5) 2 (1,5) .700
Parity c 1 (0,3) 1 (0,3) .008
Nulliparous .002
No 50,634 (56.41%) 541 (51.67%)
Yes 39,131 (43.59%) 506 (48.33%)
Gestational age group < .001
24 wks 0 d-27 wks 6 d 239 (0.27%) 23 (2.20%)
28 wks 0 d-31 wks 6 d 500 (0.56%) 16 (1.53%)
32 wks 0 d-33 wks 6 d 855 (0.95%) 18 (1.72%)
34 wks 0 d-36 wks 6 d 6190 (6.90%) 87 (8.31%)
37 wks 0 d-38 wks 6 d 26,702 (29.75%) 306 (29.23%)
39 wks 0 d-40 wks 6 d 48,503 (54.03%) 497 (47.47%)
41 wks 0 d-41 wks 6 d 6212 (6.92%) 95 (9.07%)
42 wks 0 d and above 564 (0.63%) 5 (0.48%)
BMI at admission, kg/m 2 .184
<18.5 55 (0.06%) 1 (0.10%)
18.5–25 12,323 (13.74%) 138 (13.18%)
25–30 30,597 (34.09%) 357 (34.10%)
30–35 19,428 (21.64%) 227 (21.68%)
35–40 7794 (8.68%) 94 (8.98%)
≥40 4325 (4.82%) 69 (6.59%)
Missing 15,243 (16.98%) 161 (15.38%)
Race .039
Non-Hispanic white 48,848 (54.42%) 552 (52.72%)
Non-Hispanic black 16,087 (17.92%) 193 (18.43%)
Hispanic 14,736 (16.42%) 204 (19.48%)
Asian/Pacific Islander 3203 (3.57%) 25 (2.39%)
Others 1854 (2.07%) 22 (2.10%)
Unknown/declined 5037 (5.61%) 51 (4.87%)
Stillbirth < .001˦
No 89,511 (99.72%) 1016 (97.04%)
Yes 254 (0.28%) 31 (2.96%)
Stillbirth, GA 24 wks 0 d to 27 wks 6 d .003˦
No 199 (83.26%) 11 (47.83%)
Yes 40 (16.74%) 12 (52.17%)
Stillbirth, GA 28 wks 0 d to 31 wks 6 d .01˦
No 458 (91.60%) 11 (68.75%)
Yes 42 (8.40%) 5 (31.25%)
Stillbirth, GA 32 wks 0 d to 33 wks 0 d .042˦
No 819 (95.79%) 15 (83.33%)
Yes 36 (4.21%) 3 (16.67%)
Stillbirth, GA 34 wks 0 d to 36 wks 6 d < .001˦
No 6135 (99.11%) 81 (93.10%)
Yes 55 (0.89%) 6 (6.90%)
Stillbirth, GA 37 wks 0 d to 38 wks 6 d .001˦
No 26667 (99.87%) 302 (98.69%)
Yes 35 (0.13%) 4 (1.31%)
Stillbirth, GA 39 wks 0 d to 40 wks 6 d .355˦
No 48461 (99.91%) 496 (99.80%)
Yes 42 (0.09%) 1 (0.20%)
Stillbirth, GA 41 wks 0 d to 41 wks 6 d 1.00˦
No 6209 (99.95%) 95 (100.0%)
Yes 3 (0.05%) 0
Stillbirth, GA 42 wks 0 d and above 1.00˦
No 563 (99.82%) 5 (100.0%)
Yes 1 (0.18%) 0
Duration of first stage of labor, h c 6.9 (2.1, 17.1) 495 (1.8, 24.7) < .001
Duration of second stage of labor, min c 29 (6, 124) 35 (7, 160) < .001
Duration of third stage of labor, min c 5 (2, 11) 52 (32, 1443) < .001
Hospital type < .001
University-affiliated teaching hospital 27,748 (30.91%) 444 (42.41%)
Community teaching hospital 50,498 (56.26%) 546 (52.15%)
Community nonteaching hospital 11,519 (12.83%) 57 (5.44%)
Intrauterine growth restriction d .183
No 88,270 (98.33%) 1495 (97.80%)
Yes 1495 (1.67%) 23 (2.20%)
Large for gestational age e .726
No 88672 (98.78%) 1033 (98.66%)
Yes 1093 (1.22%) 14 (1.34%)
Use of epidural < .001
No 20,211 (22.52%) 294 (28.08%)
Yes 69,554 (77.48%) 753 (71.92%)
Chorioamnionitis <.001
No 88,558 (98.66%) 1019 (97.33%)
Yes 1207 (1.34%) 28 (2.67%)
History of cesarean delivery .803
No 86,887 (96.79%) 1012 (96.66%)
Yes 2878 (3.21%) 35 (3.34%)
Oxytocin exposure .044
No 28,668 (31.94%) 365 (34.86%)
Yes 61,097 (68.06%) 682 (65.14%)
Duration from first oxytocin use to delivery, min a 298.8 (353.9) 386.6 (559.5) < .001

BMI , body mass index; GA , gestational age; ICD-9 , International Classification of Disease , 9th revision.

Coviello. Risk factors for retained placenta. Am J Obstet Gynecol 2015 .

a Other variables analyzed include history of abortion, episiotomy, induction of labor agent (misoprostol, dinoprostone, artificial rupture of membranes, or oxytocin), group B streptococcal status, duration of rupture of membranes, and episiotomy; Results are presented as number of observations (percentage) with χ 2 test unless noted as follows


b Results are presented as mean (SD) with a Student t test


c Results are presented as median (10th percentile, 90th percentile) with Wilcoxon rank sum test


d Intrauterine growth restriction (ICD-9)


e Large for gestational age (ICD-9).



They were also more likely to have a stillbirth (3.0% vs 0.3%; P < .001), chorioamnionitis (2.7% vs 1.3%; P < .001), and a longer length of first and second stages of labor ( P < .001). Women with retained placenta had a significantly higher rate of postpartum hemorrhage than women without retained placenta (11.56% vs 3.13%; P < .001). However, no significant difference was found in the rate of postpartum blood transfusion between the women with a retained placenta and the women without a retained placenta (7.02% vs 5.32%; P = .092).


After stratifying by parity and adjusting for confounding factors, multiple significant risk factors for retained placenta in both nulliparous and multiparous women were identified ( Tables 2 and 3 , respectively). Regardless of parity, risk factors included increasing maternal age >30 years, early preterm delivery <27 6/7 weeks compared with 34 0/7 weeks or later ( Figures 2 and 3 ), and stillbirth and delivery in a university-affiliated or community teaching hospital. Maternal BMI, chorioamnionitis, and IUGR had no association with retained placenta.



Table 2

Incidence and adjusted odds ratios of risk factors for retained placenta in nulliparous women















































































































































































































Nulliparous Retained placenta AOR b (95% CI)
Risk factor a No, n (%) Yes, n (%)
Age, y
<20 8273 (21.1) 88 (17.4) 0.87 (0.64–1.17)
20–24 14,896 (38.1) 166 (32.8) 0.98 (0.77–1.25)
25–29 9511 (24.3) 109 (21.5) Reference
30–34 4705 (12.0) 88 (17.4) 1.50 (1.12–2.01)
35–39 1479 (3.8) 41 (8.1) 2.02 (1.39–2.95)
≥40 267 (0.68) 14 (2.8) 3.12 (1.73–5.67)
Gestational age, wks
24/0–27/6 144 (0.37) 11 (2.2) Reference
28/0–31/6 262 (0.67) 10 (2.0) 0.53 (0.21–1.36)
32/0–33/6 439 (1.1) 12 (2.37) 0.54 (0.22–1.33)
34/0–36/6 2789 (7.1) 45 (8.9) 0.44 (0.20–0.95)
37/0–38/6 10747 (27.5) 137 (27.1) 0.41 (0.19–0.89)
39/0–40/6 21139 (54.0) 243 (48.02) 0.39 (0.18–0.82)
41–41/6 3365 (8.6) 47 (9.3) 0.39 (0.17–0.87)
≥42/0 246 (0.63) 1 (0.20) 0.11 (0.01–0.93)
BMI at admission
<18.5 36 (0.1) 1 (0.2) 1.65 (0.21–13.12)
18.5–24.9 6030 (15.4) 74 (14.6) Reference
25–29.9 13,744 (35.1) 175 (34.6) 1.0 (0.76–1.32)
30–34.9 7906 (20.2) 99 (19.6) 0.88 (0.65–1.20)
35–39.9 2959 (7.6) 40 (7.9) 0.93 (0.62–1.38)
≥40 1531 (9.1) 32 (6.3) 1.34 (0.87–2.07)
Missing 6925 (17.7) 85 (16.8) 0.87 (0.61–1.23)
Race
Non-Hispanic black 6889 (17.6) 71 (14.0) 0.63 (0.47–0.86)
Non-Hispanic white 20,966 (53.6) 287 (56.7) Reference
Hispanic 6161 (15.7) 93 (18.4) 1.11 (0.84–1.46)
Asian/Pacific Islander 1668 (4.3) 16 (3.2) 0.80 (0.47–1.35)
Stillbirth 142 (0.36) 18 (3.6) 5.85 (3.22–10.63)
Hospital type
University affiliated teaching 12,405 (31.7) 193 (38.1) 2.50 (1.2–5.19)
Community teaching 22,612 (57.8) 293 (57.9) 2.47 (1.52–4.00)
Community nonteaching 4114 (10.5) 20 (4.0) Reference
Duration first stage, h c 8.72 (3.27, 20.4) 11.29 (4.07, 30.27) 1.01 (1.01–1.02)
Duration second stage, h c 0.98 (0.27, 2.7) 1.23 (0.27, 3.25) 1.06 (1.02–1.10)
IUGR d 813 (2.1) 14 (2.8) 1.11 (0.63–1.94)
Chorioamnionitis 902 (2.3) 22 (4.35) 1.36 (0.87–2.14)
Epidural 31,961 (81.7) 387 (76.5) 0.70 (0.56–0.90)

AOR , adjusted odds ratio; BMI , body mass index; CI , confidence interval; GA , gestational age; ICD-9 , International Classification of Disease , 9th revision; IUGR , intrauterine fetal growth restriction.

Coviello. Risk factors for retained placenta. Am J Obstet Gynecol 2015 .

a Other risk factors analyzed but not listed above include the following: gravidity, other race, history of abortion, large for gestational age, intrauterine growth restriction, duration of rupture of membranes, method of induction, oxytocin use, and antepartum group B streptococcal status


b AOR


c Results are presented as median (10th percentile, 90th percentile) with Wilcoxon rank sum test


d IUGR (ICD-9).



Table 3

Incidence and adjusted odds ratios of risk factors for retained placenta in multiparous women




















































































































































































































Multiparous a Retained placenta AOR (95% CI)
Risk factor No, n (%) Yes, n (%)
Age, y
<20 1362 (2.7) 14 (2.6) 0.92 (0.52–1.61)
20–24 10,668 (21.1) 128 (23.7) 1.22 (0.95–1.56)
25–29 17,501 (34.6) 146 (27.0) Reference
30–34 13,561 (26.8) 140 (25.9) 1.28 (1.01–1.62)
35–39 6207 (12.3) 85 (15.7) 1.59 (1.20–2.10)
≥40 1335 (2.6) 28 (5.2) 2.44 (1.59–3.75)
Gestational age, weeks
24/0–27/6 95 (0.19) 12 (2.3) Reference
28/0–31/6 238 (0.5) 6 (1.1) 0.26 (0.09–0.77)
32/0–33/6 416 (0.8) 6 (1.1) 0.18 (0.06–0.53)
34/0–36/6 3401 (6.7) 42 (7.8) 0.18 (0.70–0.42)
37/0–38/6 15,955 (31.5) 169 (31.2) 0.17 (0.08–0.41)
39–40/6 27,364 (54.0) 254 (47.0) 0.16 (0.07–0.38)
41/0–41/6 2847 (5.6) 48 (8.9) 0.25 (0.10–0.60)
≥42/0 318 (0.6) 4 (0.7) 0.21 (0.06–0.79)
BMI at admission, kg/m 2
<18.5 19 (0.1) 0 (0)
18.5–24.9 6293 (12.4) 64 (11.8) Reference
25–29.9 16853 (33.3) 182 (33.6) 1.08 (0.81–1.45)
30–34.9 11522 (22.8) 128 (23.7) 1.02 (0.78–1.39)
35–39.9 4835 (9.6) 54 (10.0) 1.00 (0.69–1.46)
≥40 2794 (5.5) 37 (6.8) 1.16 (0.76–1.77)
Missing 8318 (16.4) 76 (14.1) 1.04 (0.72–1.51)
Race
Non-Hispanic black 9198 (18.2) 122 (22.6) 0.952 (0.73–1.24)
Non-Hispanic white 27882 (55.1) 265 (49.0) Reference
Hispanic 8575 (16.9) 111 (20.5) 1.1 (0.82–1.38)
Asian/Pacific Islander 1535 (3.0) 9 (1.7) 0.79 (0.40–1.54)
Stillbirth 112 (0.22) 13 (2.40) 4.47 (2.06–9.68)
Hospital type
University-affiliated teaching 15343 (30.3) 241 (46.4) 2.22 (1.03–4.80)
Community teaching 27886 (55.1) 253 (46.8) 1.93 (1.31–2.76)
Community nonteaching 7405 (14.6) 37 (6.8) Reference
Duration first stage, h b 5.78 (1.55, 13.8) 6.18 (1.22, 17.3) 1.00 (0.99–1.01)
Duration second stage, h b 0.28 (0.08, 1.08) 0.3 (0.08, 1.33) 1.01 (0.97–1.05)
IUGR c 682 (1.4) 9 (1.7) 1.25 (0.63–2.48)
Chorioamnionitis 305 (0.6) 6 (1.1) 0.99 (0.41–2.43)
Epidural 37,593 (74.2) 366 (67.7) 0.86 (0.70–1.05)
History of cesarean delivery 2861 (5.7) 35 (6.5) 0.92 (0.65–1.32)

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 5, 2017 | Posted by in GYNECOLOGY | Comments Off on Risk factors for retained placenta

Full access? Get Clinical Tree

Get Clinical Tree app for offline access